Tandem Diabetes Care, Inc. Operating Expenses
Tandem Diabetes Care, Inc. (TNDM) reported Operating Expenses of $158.57 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Tandem Diabetes Care, Inc. operating expenses for the quarter ending 2026-06-30 was $158.57M, a 10.75% decline year-over-year.
- Tandem Diabetes Care, Inc. operating expenses for the quarter ending 2026-03-31 was $154.22M, a 35.55% decline year-over-year.
- Tandem Diabetes Care, Inc. operating expenses for the quarter ending 2025-12-31 was $159.17M, a 0.72% increase year-over-year.
- Tandem Diabetes Care, Inc. operating expenses for the quarter ending 2025-09-30 was $157.16M, a 4.25% increase year-over-year.
- Tandem Diabetes Care, Inc. operating expenses for fiscal 2025 was $733.27M, a 24.56% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. operating expenses for fiscal 2024 was $588.70M, a 2.03% decline from fiscal 2023.
- Tandem Diabetes Care, Inc. operating expenses for fiscal 2023 was $600.92M, a 18.80% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. operating expenses for fiscal 2022 was $505.83M, a 43.07% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $158.57M 10-Q · filed 2026-08-06 | $312.79M 10-Q · filed 2026-08-06 | $471.96M derived: sum of 3 quarters · filed 2026-08-06 | $629.12M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $154.22M 10-Q · filed 2026-05-07 | $313.39M derived: sum of 2 quarters · filed 2026-05-07 | $470.54M derived: sum of 3 quarters · filed 2026-05-07 | $648.21M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $159.17M 10-K · filed 2026-02-19 | $316.32M derived: sum of 2 quarters · filed 2026-02-19 | $493.99M derived: sum of 3 quarters · filed 2026-08-06 | $733.27M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $157.16M 10-Q · filed 2025-11-06 | $334.82M derived: sum of 2 quarters · filed 2026-08-06 | $574.11M 10-Q · filed 2025-11-06 | $732.14M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $177.66M 10-Q · filed 2026-08-06 | $416.95M 10-Q · filed 2026-08-06 | $574.99M derived: sum of 3 quarters · filed 2026-08-06 | $725.73M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $239.28M 10-Q · filed 2026-05-07 | $397.32M derived: sum of 2 quarters · filed 2026-05-07 | $548.07M derived: sum of 3 quarters · filed 2026-05-07 | $691.63M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $158.04M 10-K · filed 2026-02-19 | $308.78M derived: sum of 2 quarters · filed 2026-02-19 | $452.35M derived: sum of 3 quarters · filed 2026-02-19 | $588.70M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $150.75M 10-Q · filed 2025-11-06 | $294.31M derived: sum of 2 quarters · filed 2025-11-06 | $430.66M 10-Q · filed 2025-11-06 | $559.02M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $143.57M 10-Q · filed 2025-08-06 | $279.92M 10-Q · filed 2025-08-06 | $408.27M derived: sum of 3 quarters · filed 2025-08-06 | $529.57M derived: sum of 4 quarters · filed 2025-08-06 | |||
| 2024-03-31 | $136.35M 10-Q · filed 2025-04-30 | $264.70M derived: sum of 2 quarters · filed 2025-04-30 | $386.00M derived: sum of 3 quarters · filed 2025-04-30 | $526.55M derived: sum of 4 quarters · filed 2025-04-30 | |||
| 2023-12-31 | $128.35M 10-K · filed 2025-02-26 | $249.65M derived: sum of 2 quarters · filed 2025-02-26 | $390.20M derived: sum of 3 quarters · filed 2025-02-26 | $600.92M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $121.30M 10-Q · filed 2024-11-06 | $261.84M derived: sum of 2 quarters · filed 2024-11-06 | $472.56M 10-Q · filed 2024-11-06 | $605.87M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $140.54M 10-Q · filed 2024-08-01 | $351.27M 10-Q · filed 2024-08-01 | $484.57M derived: sum of 3 quarters · filed 2024-08-01 | $636.49M derived: sum of 4 quarters · filed 2024-08-01 | |||
| 2023-03-31 | $210.72M 10-Q · filed 2024-05-02 | $344.02M derived: sum of 2 quarters · filed 2024-05-02 | $495.94M derived: sum of 3 quarters · filed 2024-05-02 | $610.13M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $133.30M 10-K · filed 2024-02-21 | $285.22M derived: sum of 2 quarters · filed 2024-02-21 | $399.40M derived: sum of 3 quarters · filed 2024-02-21 | $505.83M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $151.92M 10-Q · filed 2023-11-01 | $266.10M derived: sum of 2 quarters · filed 2023-11-01 | $372.53M 10-Q · filed 2023-11-01 | $473.52M derived: sum of 4 quarters · filed 2023-11-01 | |||
| 2022-06-30 | $114.19M 10-Q · filed 2023-08-03 | $220.62M 10-Q · filed 2023-08-03 | $321.61M derived: sum of 3 quarters · filed 2023-08-03 | $410.63M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | $106.43M 10-Q · filed 2023-05-03 | $207.42M derived: sum of 2 quarters · filed 2023-05-03 | $296.45M derived: sum of 3 quarters · filed 2023-05-03 | $383.47M derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | $100.99M 10-K · filed 2023-02-22 | $190.02M derived: sum of 2 quarters · filed 2023-02-22 | $277.04M derived: sum of 3 quarters · filed 2023-02-22 | $353.56M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $89.03M 10-Q · filed 2022-11-02 | $176.05M derived: sum of 2 quarters · filed 2022-11-02 | $252.57M 10-Q · filed 2022-11-02 | $324.46M derived: sum of 4 quarters · filed 2022-11-02 | |||
| 2021-06-30 | $87.02M 10-Q · filed 2022-08-03 | $163.55M 10-Q · filed 2022-08-03 | $235.44M derived: sum of 3 quarters · filed 2022-08-03 | $301.76M derived: sum of 4 quarters · filed 2022-08-03 | |||
| 2021-03-31 | $76.52M 10-Q · filed 2022-05-04 | $148.42M derived: sum of 2 quarters · filed 2022-05-04 | $214.74M derived: sum of 3 quarters · filed 2022-05-04 | $281.17M derived: sum of 4 quarters · filed 2022-05-04 | |||
| 2020-12-31 | $71.89M 10-K · filed 2022-02-22 | $138.22M derived: sum of 2 quarters · filed 2022-02-22 | $204.64M derived: sum of 3 quarters · filed 2022-02-22 | $268.48M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $66.32M 10-Q · filed 2021-11-03 | $132.75M derived: sum of 2 quarters · filed 2021-11-03 | $196.58M 10-Q · filed 2021-11-03 | $254.71M derived: sum of 4 quarters · filed 2021-11-03 | |||
| 2020-06-30 | $66.43M 10-Q · filed 2021-08-04 | $130.26M 10-Q · filed 2021-08-04 | $188.39M derived: sum of 3 quarters · filed 2021-08-04 | $245.08M derived: sum of 4 quarters · filed 2021-08-04 | |||
| 2020-03-31 | $63.83M 10-Q · filed 2021-05-05 | $121.96M derived: sum of 2 quarters · filed 2021-05-05 | $178.65M derived: sum of 3 quarters · filed 2021-05-05 | $230.42M derived: sum of 4 quarters · filed 2021-05-05 | |||
| 2019-12-31 | $58.13M 10-K · filed 2021-02-24 | $114.81M derived: sum of 2 quarters · filed 2021-02-24 | $166.58M derived: sum of 3 quarters · filed 2021-02-24 | $210.93M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $56.69M 10-K · filed 2021-02-24 | $108.46M derived: sum of 2 quarters · filed 2021-02-24 | $152.81M 10-Q · filed 2020-11-05 | $193.78M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $51.77M 10-K · filed 2021-02-24 | $96.12M 10-Q · filed 2020-07-30 | $137.09M derived: sum of 3 quarters · filed 2021-02-24 | $174.60M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $44.35M 10-K · filed 2021-02-24 | $85.33M derived: sum of 2 quarters · filed 2021-02-24 | $122.83M derived: sum of 3 quarters · filed 2021-02-24 | $151.91M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $40.98M 10-K · filed 2020-02-24 | $78.48M derived: sum of 2 quarters · filed 2020-02-24 | $107.56M derived: sum of 3 quarters · filed 2020-02-24 | $134.45M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $37.51M 10-K · filed 2020-02-24 | $66.59M derived: sum of 2 quarters · filed 2020-02-24 | $93.48M 10-Q · filed 2019-11-04 | $120.53M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $29.08M 10-K · filed 2020-02-24 | $55.97M 10-Q · filed 2019-08-01 | $83.02M derived: sum of 3 quarters · filed 2020-02-24 | $108.06M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $26.89M 10-K · filed 2020-02-24 | $53.94M derived: sum of 2 quarters · filed 2020-02-24 | $78.98M derived: sum of 3 quarters · filed 2020-02-24 | $105.95M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $27.05M 10-K · filed 2019-02-26 | $52.09M derived: sum of 2 quarters · filed 2019-02-26 | $79.06M derived: sum of 3 quarters · filed 2019-02-26 | $107.04M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $25.04M 10-K · filed 2019-02-26 | $52.01M derived: sum of 2 quarters · filed 2019-02-26 | $79.99M 10-Q · filed 2018-11-01 | $103.40M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $26.97M 10-K · filed 2019-02-26 | $54.95M 10-Q · filed 2018-07-30 | $78.36M derived: sum of 3 quarters · filed 2019-02-26 | $105.20M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $27.98M 10-K · filed 2019-02-26 | $51.39M derived: sum of 2 quarters · filed 2019-02-26 | $78.23M derived: sum of 3 quarters · filed 2019-02-26 | $103.46M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $23.41M 10-K · filed 2018-03-01 | $50.25M derived: sum of 2 quarters · filed 2018-03-01 | $75.48M derived: sum of 3 quarters · filed 2018-03-01 | $101.64M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $26.84M 10-K · filed 2018-03-01 | $52.07M derived: sum of 2 quarters · filed 2018-03-01 | $78.23M 10-Q · filed 2017-10-26 | $102.91M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $25.23M 10-K · filed 2018-03-01 | $51.39M 10-Q · filed 2017-07-27 | $76.07M derived: sum of 3 quarters · filed 2018-03-01 | $100.29M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $26.17M 10-K · filed 2018-03-01 | $50.84M derived: sum of 2 quarters · filed 2018-03-01 | $75.06M derived: sum of 3 quarters · filed 2018-03-01 | $98.53M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $24.68M 10-K · filed 2017-03-08 | $24.68M 10-K · filed 2016-02-24 | $48.90M derived: sum of 2 quarters · filed 2017-03-08 | $72.37M derived: sum of 3 quarters · filed 2017-03-08 | $95.58M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $24.22M 10-K · filed 2017-03-08 | $47.69M derived: sum of 2 quarters · filed 2017-03-08 | $70.91M 10-Q · filed 2016-11-01 | $94.94M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $23.47M 10-K · filed 2017-03-08 | $46.69M 10-Q · filed 2016-07-28 | $70.73M derived: sum of 3 quarters · filed 2017-03-08 | $94.13M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $23.22M 10-K · filed 2017-03-08 | $47.26M derived: sum of 2 quarters · filed 2017-03-08 | $70.66M derived: sum of 3 quarters · filed 2017-03-08 | $92.43M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $24.04M 10-K · filed 2017-03-08 | $47.44M derived: sum of 2 quarters · filed 2017-03-08 | $69.21M derived: sum of 3 quarters · filed 2017-03-08 | $90.91M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $23.40M 10-K · filed 2017-03-08 | $23.40M 10-Q · filed 2014-11-06 | $45.17M derived: sum of 2 quarters · filed 2017-03-08 | $66.87M 10-Q · filed 2015-10-29 | $66.87M 10-Q · filed 2014-11-06 | $84.52M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2014-06-30 | $21.77M 10-Q · filed 2014-07-31 | $43.47M 10-Q · filed 2015-07-30 | $43.47M 10-Q · filed 2014-07-31 | $61.12M derived: sum of 3 quarters · filed 2017-03-08 | $75.78M derived: sum of 4 quarters · filed 2017-03-08 | ||
| 2014-03-31 | $21.70M 10-K · filed 2017-03-08 | $21.70M 10-Q · filed 2014-05-06 | $39.35M derived: sum of 2 quarters · filed 2017-03-08 | $54.02M derived: sum of 3 quarters · filed 2017-03-08 | $68.10M derived: sum of 4 quarters · filed 2017-03-08 | ||
| 2013-12-31 | $17.65M 10-K · filed 2015-02-24 | $32.31M derived: sum of 2 quarters · filed 2015-02-24 | $46.39M derived: sum of 3 quarters · filed 2015-02-24 | $55.60M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $14.66M 10-K · filed 2015-02-24 | $14.66M 10-Q · filed 2014-11-06 | $28.74M derived: sum of 2 quarters · filed 2015-02-24 | $37.95M 10-Q · filed 2014-11-06 | |||
| 2013-06-30 | $14.08M 10-K · filed 2015-02-24 | $14.08M 10-Q · filed 2014-07-31 | $23.29M 10-Q · filed 2014-07-31 | ||||
| 2013-03-31 | $9.21M 10-K · filed 2015-02-24 | $9.21M 10-Q · filed 2014-05-06 | |||||
| 2012-12-31 | $31.70M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |